Efficacy of Tildrakizumab for the Treatment of Difficult-to-Treat Areas: Scalp, Nail, Palmoplantar and Genital Psoriasis

Tildrakizumab, an IL-23 inhibitor, is effective and safe for the improvement of moderate-to-severe chronic plaque psoriasis. However, little evidence is available on the use of this biologic in psoriasis in difficult-to-treat locations. In this retrospective analysis, we treated patients with 100 mg...

Descripción completa

Detalles Bibliográficos
Autores principales: Galluzzo, Marco, Talamonti, Marina, Cioni, Arnaldo, Maffei, Virginia, Shumak, Ruslana Gaeta, Tofani, Lorenzo, Bianchi, Luca, Campione, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100809/
https://www.ncbi.nlm.nih.gov/pubmed/35566756
http://dx.doi.org/10.3390/jcm11092631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100809/
https://www.ncbi.nlm.nih.gov/pubmed/35566756
http://dx.doi.org/10.3390/jcm11092631

Ejemplares similares